Description
Description
This page contains brief details about the drug erlotinib, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Erlotinib is a targeted anticancer treatment drug that was approved for its medical use on 18th November 2004
Mechanism of Action of Erlotinib
Erlotinib is a biological agent that acts as targeted drug therapy in cancer treatment. It is an anticancer medication that belongs to the category of tyrosine kinase inhibitors. It acts against a protein called EGFR tyrosine kinase and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Erlotinib is prescribed alone and also as a maintenance therapy.
Uses of Erlotinib
Erlotinib has been developed to treat advanced and metastatic non-small cell lung cancer due to a mutation in the EGFR gene which did not improve after chemotherapy treatment or has worsened after 4 cycles of chemotherapy.
Erlotinib Dosage available
Erlotinib is available in the form of tablets in doses 100mg and 150mg. the usual recommended dose is 150mg per day. Your healthcare provider will calculate the ideal dose according to your condition. Take Erlotinib Tablet with a large glass of water an hour before food or two hours after meals.
